Wang Shurong, Li Dongjie, Li Guangle, Duan Naixin, He Chang, Meng Junlong, Cheng Yanfen, Geng Xueran, Hou Ludan, Chang Mingchang, Xu Lijing
College of Food Science and Engineering, Shanxi Agricultural University, Taigu 030801, China.
Shanxi Engineering Research Center of Edible Fungi, Taigu 030801, China.
Foods. 2024 Jul 6;13(13):2148. doi: 10.3390/foods13132148.
polysaccharide (MIP) has been proven to have obvious hypoglycemic effects on mice with type 2 diabetes (T2DM). This study looked at the functional and rheological characteristics of MIP, and investigated the effects of MIP on the human fecal microbiota through in vitro fermentation experiments. The outcomes demonstrate the excellent oil-holding capacity, emulsifying, foaming, and rheological characteristics of MIP. After salivary gastrointestinal digestion, the Mw of MIP decreased from 398.2 kDa and 21.5 kDa to 21.9 kDa and 11.7 kDa. By 16S rRNA sequencing of bacteria fermented in vitro, it was found that MIP did not improve the richness and diversity of intestinal microorganisms, but it may exert an anti-T2DM function by significantly increasing the relative abundance of Firmicutes and promoting , , and proliferation. could also be inhibited to improve the intestinal microenvironment. In addition, the fermentation of MIP increased the total short-chain fatty acid (SCFA) concentration from 3.23 mmol/L to 39.12 mmol/L, and the propionic acid content increased significantly. In summary, MIP has excellent processing performance and is expected to exert potential anti-T2DM activity through the human intestinal microbiota, which has broad market prospects.
多糖(MIP)已被证明对2型糖尿病(T2DM)小鼠具有明显的降血糖作用。本研究观察了MIP的功能和流变学特性,并通过体外发酵实验研究了MIP对人体粪便微生物群的影响。结果表明MIP具有优异的持油能力、乳化、发泡和流变学特性。经唾液胃肠消化后,MIP的分子量从398.2 kDa和21.5 kDa降至21.9 kDa和11.7 kDa。通过对体外发酵细菌的16S rRNA测序发现,MIP并没有提高肠道微生物的丰富度和多样性,但它可能通过显著增加厚壁菌门的相对丰度并促进、、和增殖来发挥抗T2DM功能。也可以被抑制以改善肠道微环境。此外,MIP发酵使总短链脂肪酸(SCFA)浓度从3.23 mmol/L增加到39.12 mmol/L,丙酸含量显著增加。综上所述,MIP具有优异的加工性能,有望通过人体肠道微生物群发挥潜在的抗T2DM活性,具有广阔的市场前景。